Cargando…
Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
OBJECTIVE: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) eating pattern on cardiometabolic risks in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A randomized crossover clinical trial was undertaken in 31 type 2 diabetic patients. For 8 weeks, participants w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005461/ https://www.ncbi.nlm.nih.gov/pubmed/20843978 http://dx.doi.org/10.2337/dc10-0676 |
_version_ | 1782194094507819008 |
---|---|
author | Azadbakht, Leila Fard, Nafiseh Rashidi Pour Karimi, Majid Baghaei, Mohammad Hassan Surkan, Pamela J. Rahimi, Majid Esmaillzadeh, Ahmad Willett, Walter C. |
author_facet | Azadbakht, Leila Fard, Nafiseh Rashidi Pour Karimi, Majid Baghaei, Mohammad Hassan Surkan, Pamela J. Rahimi, Majid Esmaillzadeh, Ahmad Willett, Walter C. |
author_sort | Azadbakht, Leila |
collection | PubMed |
description | OBJECTIVE: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) eating pattern on cardiometabolic risks in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A randomized crossover clinical trial was undertaken in 31 type 2 diabetic patients. For 8 weeks, participants were randomly assigned to a control diet or the DASH eating pattern. RESULTS: After following the DASH eating pattern, body weight (P = 0.007) and waist circumference (P = 0.002) reduced significantly. Fasting blood glucose levels and A1C decreased after adoption of the DASH diet (−29.4 ± 6.3 mg/dl; P = 0.04 and −1.7 ± 0.1%; P = 0.04, respectively). After the DASH diet, the mean change for HDL cholesterol levels was higher (4.3 ± 0.9 mg/dl; P = 0.001) and LDL cholesterol was reduced (−17.2 ± 3.5 mg/dl; P = 0.02). Additionally, DASH had beneficial effects on systolic (−13.6 ± 3.5 vs. −3.1 ± 2.7 mmHg; P = 0.02) and diastolic blood pressure (−9.5 ± 2.6 vs. −0.7 ± 3.3 mmHg; P = 0.04). CONCLUSIONS: Among diabetic patients, the DASH diet had beneficial effects on cardiometabolic risks. |
format | Text |
id | pubmed-3005461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-30054612012-01-01 Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial Azadbakht, Leila Fard, Nafiseh Rashidi Pour Karimi, Majid Baghaei, Mohammad Hassan Surkan, Pamela J. Rahimi, Majid Esmaillzadeh, Ahmad Willett, Walter C. Diabetes Care Original Research OBJECTIVE: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) eating pattern on cardiometabolic risks in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A randomized crossover clinical trial was undertaken in 31 type 2 diabetic patients. For 8 weeks, participants were randomly assigned to a control diet or the DASH eating pattern. RESULTS: After following the DASH eating pattern, body weight (P = 0.007) and waist circumference (P = 0.002) reduced significantly. Fasting blood glucose levels and A1C decreased after adoption of the DASH diet (−29.4 ± 6.3 mg/dl; P = 0.04 and −1.7 ± 0.1%; P = 0.04, respectively). After the DASH diet, the mean change for HDL cholesterol levels was higher (4.3 ± 0.9 mg/dl; P = 0.001) and LDL cholesterol was reduced (−17.2 ± 3.5 mg/dl; P = 0.02). Additionally, DASH had beneficial effects on systolic (−13.6 ± 3.5 vs. −3.1 ± 2.7 mmHg; P = 0.02) and diastolic blood pressure (−9.5 ± 2.6 vs. −0.7 ± 3.3 mmHg; P = 0.04). CONCLUSIONS: Among diabetic patients, the DASH diet had beneficial effects on cardiometabolic risks. American Diabetes Association 2011-01 2010-09-15 /pmc/articles/PMC3005461/ /pubmed/20843978 http://dx.doi.org/10.2337/dc10-0676 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Azadbakht, Leila Fard, Nafiseh Rashidi Pour Karimi, Majid Baghaei, Mohammad Hassan Surkan, Pamela J. Rahimi, Majid Esmaillzadeh, Ahmad Willett, Walter C. Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial |
title | Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial |
title_full | Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial |
title_fullStr | Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial |
title_full_unstemmed | Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial |
title_short | Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial |
title_sort | effects of the dietary approaches to stop hypertension (dash) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005461/ https://www.ncbi.nlm.nih.gov/pubmed/20843978 http://dx.doi.org/10.2337/dc10-0676 |
work_keys_str_mv | AT azadbakhtleila effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial AT fardnafisehrashidipour effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial AT karimimajid effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial AT baghaeimohammadhassan effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial AT surkanpamelaj effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial AT rahimimajid effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial AT esmaillzadehahmad effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial AT willettwalterc effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial |